The Bottom Line Pharmacy Podcast: Sykes & Company, P.A.

Inside NCPA: Advocacy Wins, Owner Resources, Real-World ROI with Mark Ey and Hashim Zaibak

Send a textSend a textSchedule an Rx AssessmentIs NCPA really worth it for independent pharmacy owners? What's the real world ROI of being apart of NCPA? In this episode, Scotty Sykes, CPA, CFP, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Mark Ey, COO of NCPA and Hashim Zaibak, PharmD, CEO of Hayat Pharmacy to break down what NCPA actually does for independent community pharmacies and why so many owners miss the real value hiding in plain sight.We cover:Why NCPA advocacy matters (and how it amplifies the patient voice in Washington)Ownership Workshop and other owner resourcesThe biggest business lesson many owners learn too late: profit ≠ cash flowWhy LTC is a major opportunity for the next 5–10 yearsStudent and young pharmacist pathways (school visits, internships, and building the next generation)And more!More About NCPA:Founded in 1898, the National Community Pharmacists Association is the voice for the community pharmacist, representing over 18,900 pharmacies that employ more than 235,000 individuals nationwide.They are rooted in the communities where they are located and are America’s most accessible health care providers.Likewise, they are community leaders actively involved in community-oriented public health, civic, and volunteer projects. Many hold local elected offices; others serve as state legislators.Stay connected with NCPA:NCPA WebsiteNCPA LinkedInNCPA InstagramNCPA FacebookNCPA Twitter (X)NCPA YouTubeCheck out all our social media:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP Twitter More resources on this topic:NCPA Membership portalPodcast - Pharmacy Leadership Amplified with Dr. Hashim Zaibak, PharmDPodcast - From Zero to Community Pharmacy Hero Featuring Hashim Zaibak, PharmD

Infusion Revolution Series | Building a Resilient Infusion Business Model with Jordan Akers VanName

Send a textInfusion is booming and it’s not just because of an aging population. As technology unlocks new gene therapies, autoimmune treatments, and ultra-rare specialty drugs, infusion pharmacies are being pushed to scale faster, operate tighter, and deliver a better patient experience than ever.In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP® and Austin Murray sit down with Jordan VanName, RN, Owner of FusionIQ Nursing to talk about what separates a high-performing infusion operation from one that gets stuck in bottlenecks, delays, and compliance headaches.We cover:Why infusion growth is accelerating and what’s driving demandOne of the biggest operational bottleneck in Infusion pharmaciesWhy “a prescription is not an order” and what that means for complianceWhat “top notch care” really looks like from first referral to post-infusion follow-upAnd more!More About Our Guest:Jordan VanName is a seasoned healthcare leader and clinical expert with nearly two decades of experience on the frontlines of patient care and specialized medical operations. As the founder of FusionIQ Nursing Solutions, Jordan leverages her extensive background to bridge the gapsbetween clinical excellence, operational efficiency, and regulatory compliance. Jordan’s career began in 2007 at UNC Chapel Hill, where she developed a foundation in complex healthcare environments. After graduating from Alamance Community College and later South University, she began her nursing practice in 2011 at the prestigious North Carolina Jaycee Burn Center.The inspiration for FusionIQ Nursing Solutions came from Jordan’s firsthand observation of a fragmented industry. Following her career into specialty pharmacy nursing agencies, she identified a critical void: many organizations lacked the cohesive clinical and operational leadership necessary to keep pace with the rapid growth of specialty pharmaceuticals.Driven by a mission to eliminate operational inefficiencies and improve data utilization, Jordan founded FusionIQ. Today, she consults for healthcare agencies, pharmacies, and manufacturers, helping them navigate the complexities of modern medicine through innovation and high-standard clinical leadership.Beyond her professional achievements, Jordan is a dedicated wife and a mother to three children under the age of ten. She finds balance and rejuvenation through her love for the outdoors, often spending her free time gardening or enjoying the beach with her familyStay connected with Jordan and FusionIQ Nursing: Jordan's LinkedInFusionIQ Nursing WebsiteFusionIQ Nursing LinkedInStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP Twitter More resources on this topic: Podcast - Driving Independent Pharmacy Profitability in 2026Podcast – Opening an Infusion PharmacyPodcast – KPIs for the Rapid Growth Pharmacy

Protecting Pharmacy Data in the Age of Social Engineering with Chris Sykes, IT Director, MCSA, MS

Send a textSchedule an Rx AssessmentWith cybercriminal activity accelerating and AI making scams more sophisticated by the day, one of the greatest threats facing pharmacies is through social engineering. Not by hacking systems, but by manipulating people.In this episode, Austin Murray and Scotty Sykes are joined by Chris Sykes, IT Director at Sykes & Company, to break down what social engineering really is, why pharmacies are prime targets, and how these attacks are evolving through email, phone calls, text messages, and even deep-fake technology.We cover:What social engineering is and how pharmacies are being targeted todayCommon pharmacy-specific scams, including fake refill notices, insurance requests, and ACH change attemptsHow AI and deep-fake voices are raising the stakesPractical steps pharmacies can take to slow down, verify requests, and protect PHIAnd more!More About Our Guest:Chris Sykes is the Director of IT at Sykes & Company, P.A., where he has been a key part of the team since 2006. With nearly 25 years in the IT industry, Chris combines deep technical expertise with a passion for helping both the firm and its clients become more efficient, secure, and technology-driven. Chris holds a Bachelor of Science in Business Administration with a concentration in Management Information Systems and a Master of Science in Technology Systems, both from East Carolina University. Outside of work, Chris enjoys running marathons, fishing and hunting with his boys, and spending quality time with his family at the beach.Learn more about Chris Sykes:Chris Sykes LinkedInCheck out all our social media:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterMore resources on this topic:Podcast - AI, Audits, & Advocacy: The Pharmacy Survival Guide with Trenton TheidePodcast - Navigating Cybersecurity, NIST and HIPAABlog - Technology, Security and Your PharmacyBlog - Protect You and Your Pharmacy: The Growing Threat of RansomwareBlog - Backing Up Your Business DataBlog - Spot a Hacked Email or Bad WebsiteBlog - Protect Your Pharmacy Data from Hackers

KPIs for the Rapid Growth Pharmacy with Jim Hrncir, R. Ph, Owner of Las Colinas Compounding Pharmacy

Send a textSchedule an Rx AssessmentRapid growth is exciting but without the right metrics, culture, and plan, it can quietly put your pharmacy at risk.In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Jim Hrncir, R. Ph. FACP, Owner of Las Colinas Compounding Pharmacy and Wellness Center veteran compounding pharmacist and owner, to unpack what it really takes to run a sustainable compounding pharmacy through industry cycles, GLP-1 volatility, and ownership transitions.We cover:The KPIs Jim actually tracks to manage a complex compounding operationWhy cash position may be the most overlooked metric in pharmacyHow GLP-1s changed the business—and why diversification still mattersInternal succession vs. private equity: the real tradeoffsAnd more!More About Our Guest:Jim Hrncir RPh and wife Jan founded Las Colinas Pharmacy, Compounding & Wellness in 1984. Recognized as one of the pioneers of modern pharmaceutical compounding, Jim’s 1986 creation of Estradiol Transdermal Gel was the first of its kind in the United States. He is responsible for the formulation of many Bio-Identical Hormone, Dermatological, Nutritional, and Anti-Aging compounds in wide use throughout the United States. Jim was named the 2017 Compounding Pharmacist of the Year by Professional Compounding Centers of America (PCCA) and is a Fellow of the Alliance for Pharmacy Compounding (FAPC). NCPA’s magazine America’s Pharmacist featured Jim and Las Colinas Pharmacy as the cover story for December 2018.Jim has received extensive continuing education in the areas of Bio-Identical Hormones, Nutrition, Anti-Aging Medicine, Weight Management, Pain Management, Neurotransmitter Management, Natural and Functional Medicine including the use of botanical medicines, nutritional supplements, Detoxification and Purification, homeopathy and lab testing. He has lectured across the country on a variety of topics including Clinical Patient Consulting, BHRT Assessment and Case Management, Low Dose Naltrexone, Traumatic Brain Injury Treatment Protocols, and Ketamine for Treatment-Resistant Depression and PTSD.Jim is a member of Professional Compounding Centers of America (PCCA), American Academy of Anti-Aging Medicine, Age Management Medical Group, Texas Pharmaceutical Association, Alliance for Pharmacy Compounding, and the National Association of Community Pharmacists.Stay connected with Jim and Las Colinas Pharmacy: Jim's LinkedInLas Colinas Pharmacy WebsiteLas Colinas Pharmacy FacebookLas Colinas Pharmacy TikTokLas Colinas Pharmacy InstagramLas Colinas Pharmacy LinkedInStay connected with us: FacebookYouTube LinkedInInstagram More resources on this topic: Podcast - Driving Independent Pharmacy Profitability in 2026Podcast – The Startup Compounding Pharmacy Playbook

Bonus Episode: And Out Came the PBM Reform: TrumpRx, PBM Reform, and the FTC’s Signal to the Market

Send a textSchedule an Rx AssessmentWith TrumpRx officially live, the first major PBM reform in decades signed into law, and the FTC squeezing historic concessions out of Cigna/Express Scripts…Did independent pharmacy just have its “Super Bowl week?”In this bonus episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray break down what these rapid-fire developments actually mean for pharmacy owners.We cover:MFP UpdatesTrumpRx going liveFTC + Cigna/Express Scripts settlementWhat new CMS transparency could mean for pharmacy reimbursementAnd more!Stay connected with us on social media:FacebookTwitterLinkedInScotty Sykes – CPA, CFP® LinkedInMore on this topic:Podcast: Business As Usual...Until It Isn't: MDPNP's Impact on 340BPodcast: Driving Independent Pharmacy Profitability in 2026Podcast - Maximizing Med Sync